Abstract
Purpose
Our aim was to perform a dynamic study of contrast enhancement of the intestinal wall in patients with Crohn’s disease to quantitatively assess local inflammatory activity.
Materials and methods
We studied a population of 50 patients with histologically proven Crohn’s disease. Magnetic resonance imaging (MRI) was performed using a 1.5-T magnet with a phased-array coil and acquisition of T2-weighted single-shot fast spin echo (SSFSE) half Fourier sequences before intravenous administration of gadolinium, and T1-weighted fast spoiled gradient (FSPGR) fat-saturated sequences before and after contrast administration. Before the examination, patents received oral polyethylene glycol (PEG) (1,000 ml for adults; 10 ml/Kg of body weight for children). Regions of interest (ROI) were placed on the normal and diseased intestinal wall to assess signal intensity and rate of increase in contrast enhancement over time. Data were compared with the Crohn’s Disease Activity Index (CDAI).
Results
The diseased bowel wall showed early and intense uptake of contrast that increases over time until a plateau is reached. In patients in the remission phase after treatment, signal intensity was only slightly higher in diseased bowel loops than in healthy loops. There was a significant correlation between the peak of contrast uptake and CDAI.
Conclusions
Dynamic MRI is a good technique for quantifying local inflammatory activity of bowel wall in patients with Crohn’s disease.
Riassunto
Obiettivo
Studiare dinamicamente l’accumulo di contrasto della parete intestinale in pazienti con morbo di Crohn per correlarlo quantitativamente con il grado di attività di infiammazione locale.
Materiali e metodi
Abbiamo studiato un campione di 50 pazienti con diagnosi istologica di morbo di Crohn (37 in fase attiva di malattia; 13 in remissione clinica); abbiamo utilizzato un magnete da 1,5 T, bobina phased array e sequenze T2 dipendenti SSFSE half Fourier in fase precontrastografica e T1 dipendenti FSPGR fat-sat in fase pre-e post-contrastografica. Prima di eseguire l’esame è stato somministrato per os glicole polietilenico (PEG) (1000 ml per adulti; 10 ml/Kg del peso corporeo per bambini). Abbiamo tracciato ROI (region of interest) per valutare l’intensit`a del segnale nella parete intestinale normale e patologica e la percentuale d’incremento nel tempo. Tali dati sono stati correlati con un indice di attività della malattia, il Crohn’s Disease Activity Index (CDAI).
Risultati
Abbiamo osservato che la parete intestinale patologica ha un uptake contrastografico precoce ed elevato che aumenta nel tempo fino a una fase di plateau. In caso di remissione della malattia dopo terapia, per contro, si ha una significativa riduzione dell’incremento di segnale, di poco aumentato rispetto a quello delle anse normali. Inoltre abbiamo notato una buona correlazione tra il livello di massimo uptake contrastografico e il CDAI.
Conclusioni
Lo studio dinamico con risonanza magnetica (RM) ci consente di quantificare l’attività infiammatoria locale della parete intestinale.
Similar content being viewed by others
References/Bibliografia
Goebell H, Wienbeck M, Schomerus H et al (1990) Evaluation of the Crohn’s Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn’s disease. An analysis of the data from the European Cooperative Crohn’s Disease Study. Med Klin 85:573–5
Otley A, Loonen H, Parekh N et al (1999) Assessing activity of pediatric Crohn’s disease: which index to use? Gastroenterology 116:527–531
Mekhjian HS, Switz DM, Melnyk CS et al (1979) Clinical features and natural history of Crohn’s disease. Gastroenterology 58: 898–906
Polito JM, Childs B, Mellits ED et al (1996) Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111:580–586
Albert J, Scheidt T, Basler B et al (2002) Magnetic resonance imaging in diagnosis and follow-up of Crohn’s Disease — Is conventional enteroclysis still necessary? Z Gastroenterol 40:789–794
Durno CA, Sherman P, Williams T et al (2000) Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 30:170–174
Pascu M, Roznowski AB, Muller HP et al (2004) Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel. Inflamm Bowel Dis 10:373–382
Madsen SM, Thomsen HS, Schlichting P et al (1999) Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging. Abdom Imaging 24:232–239
Rieber A, Wruk D, Potthast S et al (2000) Diagnostic imaging in Crohn’s disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 15:176–181
Aschoff AJ, Zeitler H, Merkle EM et al (1997) MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases with contrast enhancement. Rofo 167:387–391
Rollandi GA, Martinoli C, Conzi R et al (1996) Magnetic resonance imaging of the small intestine and colon in Crohn’s disease. Radiol Med 91:81–85
Holzknecht N, Helmberger T, Herrmann K et al (2003) MRI in Crohn’s disease after transduodenal contrast administration using negative oral MRI contrast media. Radiologe 43:43–50
Miao YM, Koh DM, Amin Z et al (2002) Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn’s disease. Clin Radiol 57:913–918
Koh DM, Miao Y, Chinn RJ et al (2001) MR imaging evaluation of the activity of Crohn’s disease. AJR Am J Roentgenol 177:1325–1332
Laghi A, Borrelli O, Paolantonio P et al (2003) Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn’s disease. Gut 52:393–397
Rieber A, Nussle K, Reinshagen M et al (2002) MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging 27:394–399
Madsen SM, Thomsen HS, Munkholm P et al (2002) Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery. Scand J Gastroenterol 37:307–316
Hansmann HJ, Hess T, Hahmann M et al (2001) MRI in chronic inflammatory bowel disease. Rofo 173:4–11
Ganten M, Encke J, Flosdorff P et al (2003) Follow up of Crohn’s disease under therapy with hydro-MRI. Radiologe 43:26–33
Sempere GA, Martinez Sanjuan V, Medina Chulia E et al (2005) MRI evaluation of inflammatory activity in Crohn’s disease. AJR Am J Roentgenol 184:1829–1835
Laghi A, Paolantonio P, Passariello R (2005) Small bowel. Magn Reson Imaging Clin N Am 13:331–348
Schunk K, Reiter S, Kern A et al (2001) Hydro-MRI in inflammatory bowel diseases: a comparison with colonoscopy and histology. Rofo 173:731–738
Wiarda BM, Kuipers EJ, Houdijk LP et al (2005) MR enteroclysis: imaging technique of choice in diagnosis of small bowel diseases. Dig Dis Sci 50:1036–1040
Broglia L, Gigante P, Papi C et al (2003) Magnetic resonance enteroclysis imaging in Crohn’s disease. Radiol Med 106:28–35
Rohr A, Rohr D, Kuhbacher T et al (2002) Radiological assessment of small bowel obstructions: Value of conventional enteroclysis and dynamic MR-enteroclysis. Rofo 174:1158–1164
Rieber A, Wruk D, Nussle K et al (1998) MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA. Radiologe 38:23–28
Holzknecht N, Helmberger T, von Ritter C et al (1998) MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles. Radiologe 38:29–36
Schunk K, Kern A, Heussel CP et al (1999) Hydro-MRT with fast sequences in Crohn’s disease: a comparison with fractionated gastrointestinal passage. Rofo 170:338–346
Shoenut JP, Semelka RC, Silverman R et al (1993) MRI in the diagnosis of Crohn’s disease in two pregnant women. J Clin Gastroenterol 17:244–247
Magnano G, Granata C, Barabino A et al (2003) Polyethylene glycol and contrast-enhanced MRI of Crohn’s disease in children: preliminary experience. Pediatr Radiol 33:385–391
Laghi A, Paolantonio P, Iafrate F et al (2003) MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn’s disease. Radiol Med 106:18–27
Anderson CM, Brown JJ, Balfe DM et al (1994) MR imaging of Crohn disease: use of perflubron as a gastrointestinal contrast agent. J Magn Reson Imaging 4:491–496
Schunk K, Metzmann U, Kersjes W et al (1997) Follow-up of Crohn’s disease: can hydro-MRI replace fractionated gastrointestinal passage examination? Rofo 166:389–396
Godefroy C, Pilleul F, Dugougeat F et al (2005) Value of contrast-enhanced MR enterography in pediatric Crohn’s disease:preliminary study. J Radiol 86:1685–1692
Horsthuis K, Lavini Mphil C, Stoker J (2005) MRI in Crohn’s disease. J Magn Reson Imaging 22:1–12
Pauls S, Kratzer W, Rieber A et al (2003) Quantifying the inflammatory activity in Crohn’s disease using CE dynamic MRI. Rofo 175:1093–1099
Maccioni F, Viscido A, Broglia L et al (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228
Laghi A, Borrelli O, Paolantonio P et al (2003) Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn’s disease. Gut 52:393–397
Frokjaer JB, Larsen E, Steffensen E et al (2005) Magnetic resonance imaging of the small bowel in Crohn’s disease. Scand J Gastroenterol 40:832–842
Low RN, Sebrechts CP, Politoske DA et al (2002) Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 222:652–660
Hittmair K, Gomiscek G, Langenberger K et al (1994) Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 31:567–571
Schunk K, Kern A, Oberholzer K et al (2000) Hydro-MRI in Crohn’s disease: appraisal of disease activity. Invest Radiol 35:431–437
Kettritz U, Isaacs K, Warshauer DM et al (1995) Crohn’s disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 21:249–253
Schunk K (2002) Small bowel magnetic resonance imaging for inflammatory bowel disease. Top Magn Reson Imaging 13:409–425
Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al (2000) MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol 35: 707–711
Sostegni R, Daperno M, Scaglione N et al (2003) Review article: Crohn’s disease: monitoring disease activity. Aliment Pharmacol Ther 17:11–17
Schunk K, Kern A, Heussel CP et al (2000) Assessment of inflammatory activity in Crohn disease with hydro-MRI. Rofo 172:153–160
Prassopoulos P, Papanikolaou N, Grammatikakis J et al (2001) MR enteroclysis imaging of Crohn disease. Radiographics 21:S161–172
Rieber A, Aschoff A, Nussle K et al (2000) MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 10:1377–1382
Schmidt T, Reinshagen M, Brambs HJ et al (2003) Comparison of conventional enteroclysis, intestinal ultrasound and MRI-enteroclysis for determining changes in the small intestine and complications in patients with Crohn’s disease. Z Gastroenterol 41:641–648
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pupillo, V.A., Di Cesare, E., Frieri, G. et al. Assessment of inflammatory activity in Crohn’s disease by means of dynamic contrast-enhanced MRI. Radiol med 112, 798–809 (2007). https://doi.org/10.1007/s11547-007-0192-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-007-0192-y